Physical rehabilitation and symptom management still remain the mainstay of treatment for stroke, as clot removal or ...
Strokes are a medical emergency, yet imaging can capture only snapshots of how brain damage develops in the hours and days ...
South Korea’s MFDS gave regulatory clearance to SK Inc. C&C’s artificial intelligence (AI) solution to diagnose cerebral infarction called Medical Insight+ Brain Infarct on Feb. 22, as a class III ...
Even patients with acute ischemic stroke who are delayed in getting to the hospital and already have large cerebral infarcts may derive a benefit from endovascular therapy to remove the clot, ...
The prevalence of these brain changes was generally the same between those with and without a recent stroke and there were no apparent sex differences in the results. Dr Zhou said the study also ...
Factor XIa inhibitor milvexian did not provide meaningful secondary prevention over dual antiplatelet therapy for stroke survivors, the phase II trial AXIOMATIC-SSP found. In patients with recent ...
Delivering therapies to the brain remains a major challenge due to the limited permeability of the blood-brain barrier. In a ...
A secondary analysis of the phase 2 PACIFIC-STROKE trial showed that asundexian is effective for the secondary prevention of stroke in patients with stroke of atherosclerotic origin, but not those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results